期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

铂类抗癌药物的发展历程 被引量：4

The development history of antitumor platinum compounds
下载PDF
导出
摘要 铂类抗癌药物是当今肿瘤化疗的基石。本文简要介绍已经上市的几个铂类抗癌药物的研发历史。 Platinum compounds are the cornerstone of contemporary chemotherapy for malignant tumor. The history of the development of antitumor platinum compounds is reviewed in this article.
作者 梁晓华
机构地区 复旦大学附属华山医院肿瘤科
出处 《上海医药》 CAS 2013年第23期3-6,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 铂类药物 顺铂 卡铂 platinum compounds cisplatin carboplatin
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献14

  • 1Rosenberg B, van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode [J]. Nature, 1965, 205(4972): 698-699. 被引量：1
  • 2Rosenberg B, van Camp L, Trosko JE, et al. Platinum compounds: a new class of potent antitumour agents [J]. Nature, 1969, 222(5191): 385-386. 被引量：1
  • 3Lippman A, Helson C, Helson L, et al. Clinical trials of cis-diamminedichloroplatinum (NSC-119875) [J]. Cancer Treatment Rep, 1973, 57(2): 191-200. 被引量：1
  • 4Cvitkovic S, Spaulding J, Bethune V, et al. Improvement of cis-dichlorodiammineplatinum (NSCl19875) therapeutic index in an animal model [J]. Cancer, 1977, 39(4): 1357- 1361. 被引量：1
  • 5Einhorn L, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer [J]. Ann Intern Med, 1977, 87(3): 293-298. 被引量：1
  • 6Rossi A, di Maio M, Chiodini P, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small- cell lung cancer: the COCIS meta-analysis of individual patient data [J]. J Clin Oncol, 2012, 30(14): 1692-1698. 被引量：1
  • 7Alberto ME, Lucas MF, Pavelka M, et al. The second- generation anticancer drug nedaplatin: a theoretical investigation on the hydrolysis mechanism [J]. J Plays Chem B, 2009, 113(43): 14473-14479. 被引量：1
  • 8Gong Y, Ren L, Zhou L, et al. Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma [J]. Cancer Chemother Pharmacol, 2009, 64(2): 327-333. 被引量：1
  • 9Zheng J, Wang G, Yang GY, et al. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma [J]. Jpn J Clin Oncol, 2010, 40(5): 425-431. 被引量：1
  • 10de Gramont A, Tournigand C, Louvet C, et al. Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX) in pretreated patients with metastatic advanced cancer. The GERCOD [J]. Rev Med Interne, 1997, 18(10): 769-775. 被引量：1

二级参考文献7

  • 1HarstrickA,VanhoeferU,HeidemannA,etal.Druginteractionsof5-fluorouracilwitheithercisplatinorlobaplatin--anewclinicallyactiveplatinumanaloginestablishedhumancancercelllines.[J].AnticancerDrug,1997,8(4):391-395. 被引量：1
  • 2GietemaJA,VeldhuisGJ,GuchelearHJ,etal.PhaseⅡandpharmacokineticstudyoflabaplatininpatientswithrelapsedovariancancer[J].BrJCancer,1995,71(6):1302-1307. 被引量：1
  • 3DegardinM,ArmandJP,ChevallierB,etal.AclinicalscreeningcooperativegroupphaseⅡevaluationoflobaplatininadvancedheadandneckcnacer[J].InvestNewDrugs,1995,13(3):253-255. 被引量：1
  • 4JungP,BachmannP,BurkK,etal.Lobaplatinincombinationwithmethotrexateandvinblastinpatientswithtransitionalcellcarcinomaoftheurinarytract:apilotphaseⅠ/Ⅱstudy[J].EurJCancer,1995,31A(11):1891-1892. 被引量：1
  • 5KavanaghJJ,EdwardsCL,FreedmanRS,etal.Atrialoflobaplatininplatinum-resistantovariancancer[J].GynecolOncol,1995,58(1):106-109. 被引量：1
  • 6HarstrickA,BokemeyerC,ScharnofrseM,etal.Preclinicalactivityofanewplatinumanalogue,lobaplatin,incisplatin-sensitiveand-resistanthumantesticular,ovarian,andgastriccarcinomacelllines[J].JNatlCancerInst,1995,85(3):280-288. 被引量：1
  • 7SternbergCN,deMulderP,FossaS,etal.Lobaplatininadvancedurothelialtracttumor[J].AnnOncol,1997,8(7):695-596. 被引量：1

共引文献53

同被引文献64

  • 1陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465. 被引量：845
  • 2National Comprehensive Cancer Network. NCCN clinical practice guideline in oncology: Palliative Care, 2014 vl. [EB/OL]. (2014-08-14). http://www.nccn.org/professionals/ physician_gls/pdf/palliative.pdf. 被引量：1
  • 3Zomosa C, Vandergrift JL, Kalemkerian GP, et al. First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions[J]. J Natl Compr Canc Netw, 2012,10(7): 847-856. 被引量：1
  • 4Pennell NA. Selection of chemotherapy for patients with advanced non-small cell lung cancer[J]. Cleve Clin J Med, 2012(79): eS46- eS50. 被引量：1
  • 5Kolinsky DC,Hayashi SS,Karzon R,et al.Late onset hearing loss:a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens.J Pediatr Hematol Oncol 2010,32(2):119-123. 被引量：1
  • 6Knight KR,Kraemer DF,Winter C,et al.Early changes in auditory function as a result of platinum chemotherapy:use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.J Clin Oncol 2007,25(10):1190-1195. 被引量：1
  • 7Brock PR,Knight KR,Freyer DR,et al.Platinum-induced ototoxicity in children:a consensus review on mechanisms,predisposition,and protection,including a new International Society of Pediatric Oncology Boston ototoxicity scale.J Clin Oncol 2012,30(19):2408-2417. 被引量：1
  • 8Neuwelt EA,Brummett RE,Doolittle ND,et al.First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.J Pharmacol Exp Ther 1998,286(1):77-84. 被引量：1
  • 9Rybak LP,Whitworth CA,Mukherjea D,et al.Mechanisms of cisplatin-induced ototoxicity and prevention.Hear Res 2007,226(1-2):157-167. 被引量：1
  • 10Berg AL,Spitzer JB,Garvin JJ.Ototoxic impact of cisplatin in pediatric oncology patients.Laryngoscope 1999,109(11):1806-1814. 被引量：1

引证文献4

二级引证文献11

上海医药
2013年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部